Skip to content

RayStation 7

by RaySearch Laboratories AB (PUBL)

510(k) K180379

RayStation 7 is a medical device (FDA Class II; FDA product code MUJ, System, Planning, Radiation Therapy Treatment) made by RaySearch Laboratories AB (PUBL), cleared under FDA 510(k) K180379 on 25 Apr 2018, active as of 22 Oct 2026. 7 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK180379 Date25 Apr 2018ClearedStatusActive

Official records

From the FDA record

Received by the FDA
12 Feb 2018
FDA decision
25 Apr 2018 (Substantially Equivalent)
FDA review time
72 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K180379 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

7 recalls · 3 ongoing · FDA

    • Ongoing Z-2487-2025 FDA Class II initiated 8 Aug 2025

    DICOM SOP Instance UID and Series Instance UID from RayGateway, i.e. the interface to Accuray's iDMS, are not guaranteed to be unique.

    • Ongoing Z-1185-2025 FDA Class II initiated 16 Jan 2025

    Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.

    • Ongoing Z-1742-2024 FDA Class II initiated 28 Mar 2024

    Potential for reported SSD to be too high.

    • Terminated Z-0679-2019 FDA Class II initiated 12 Nov 2018

    Isocenter shifts when using dose tracking in RayStation 3.5, RayStation 4.0, RayStation 4.5, RayStation 4.7, RayStation 5, RayStation 6, RayStation 7 and RayStation 8A. In these versions, isocenter shifts in dose tracking are incorrectly interpreted according to the DICOM patient coordinate system.

    • Terminated Z-0294-2019 FDA Class II initiated 21 Sep 2018

    Robust optimization for plans using beam set + background dose is not supported in RayStation 4.5, RayStation 4.7, RayStation 5, RayStation 6 and RayStation 7.

    • Terminated Z-2497-2018 FDA Class II initiated 29 Jun 2018

    If the beam model has a highly asymmetric primary source, it is not correctly taken into account in the calculation of DMLC fields when the collimator is rotated. This could lead to potentially significant overdosage at delivery. The user must be aware of the issue to avoid incorrect dose calculations during treatment planning.

    • Terminated Z-2554-2018 FDA Class II initiated 6 Jun 2018

    The firm has learned that some RayStation/RayPlan users have commissioned machines with erroneous Beam profile correction parameters. These parameters affect the dose calculated in corners of large or off-axis fields. This effect cannot be seen in the Beam Commissioning module and dose in large or off-axis fields needs to be validated using the Beam 3D Modeling module in RayPhysics/RayPlan Physics. The user must be aware to avoid incorrect dose calculations during treatment planning.

Timeline

8 dated events

  1. Cleared FDA 510(k) K180379
  2. Recall initiated FDA recalls Z-2554-2018
  3. Recall initiated FDA recalls Z-2497-2018
  4. Recall initiated FDA recalls Z-0294-2019
  5. Recall initiated FDA recalls Z-0679-2019
  6. Recall initiated FDA recalls Z-1742-2024
  7. Recall initiated FDA recalls Z-1185-2025
  8. Recall initiated FDA recalls Z-2487-2025

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MUJ
Device class
Class II
Regulation
21 CFR Part 892.5050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Devices cleared under K180379

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K180379
UDI-DISize and differences
RayStation 7
RaySearch Laboratories AB (PUBL)
707350002010068 —On the market
RayStation 8.0
RaySearch Laboratories AB (PUBL)
8.007350002010112 —On the market

Similar devices

Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).

Other devices from RaySearch Laboratories AB (PUBL)

See all devices from RaySearch Laboratories AB (PUBL) →